
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2023-2030
In Zimbabwe, there is a thriving industry for the production of pharmaceuticals, with a number of local businesses creating a variety of pharmaceutical goods like generic medications, medical equipment, and herbal cures.
To lessen the nation's dependency on pharmaceutical imports, local manufacture is being promoted.
Despite expanding its domestic manufacturing capabilities, Zimbabwe still imports a sizable share of its pharmaceutical goods, including finished goods and active pharmaceutical ingredients (APIs).
The need for a variety of healthcare products is met in part by these imports.
Zimbabwe places a high premium on ensuring access to necessary medications.
Price limits and subsidies for necessary medications are just two of the measures and policies that have been put in place to increase accessibility and affordability.
The Zimbabwe pharmaceutical market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Zimbabwe introduced a manufacturing plan for pharmaceuticals to increase medicine production.
Additionally, by making more of the nation's vital medications available, the approach is anticipated to enhance the pharmaceutical industry's commitment to public health. Drug surplus will be exported.
Due to their medical aid societies only covering the prescribed rates for a limited number of medications, many persons who rely on medical assistance today face significant deficits when purchasing medications.
Even worse, those who do not receive medical assistance frequently forego taking recommended medications because they cannot pay the hefty costs.
Making medications available and inexpensive to citizens is the main goal of the Pharmaceutical Development Strategy.
The majority of Zimbabwe's medications are pricey because only 12% of the medications used locally are now produced in Zimbabwe; the remainder are imported.
Consequently, it is anticipated that the Pharmaceutical Manufacturing Strategy will address that.
There are public health difficulties in Zimbabwe, such as HIV/AIDS, malaria, and problems with mother and child health.
The government executes a variety of health programmes, including disease control measures and immunisation campaigns, in cooperation with international organisations like the World Health Organisation (WHO) and UNICEF to address these difficulties
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2023-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2023-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2023-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |